Down 52% in 3 Months, Is This Biotech Stock a Buy? [The Motley Fool]
Zogenix, Inc. (ZGNX)
Last zogenix, inc. earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
zogenixinc.gcs-web.com/investor-overview
Company Research
Source: The Motley Fool
On Feb. 7, shares of Zogenix ( NASDAQ:ZGNX After its most recent slump, Zogenix's shares are down by % over the past three months, while the 00 Pinning its hopes on Fintepla Zogenix currently has no approved products on the market; hence the importance of receiving regulatory approval for Fintepla as soon as possible. Fintepla is a potential treatment for seizures associated with Dravet syndrome, a rare form of epilepsy. Fintepla is also being investigated as a treatment for seizures associated with Lennox-Gastaut syndrome (LGS), another rare form of epilepsy. Zogenix originally submitted an NDA to the FDA in February 09, along with a marketing authorization application to the European Medicine Agency (EMA) for Fintepla around the same time. Image Source: Getty Images. However, the FDA determined the NDA was "not sufficiently complete to permit a substantive review," requiring Zogenix to resubmit the application in September 09. Despite this setback, Zogenix has high hopes for Fintep
Show less
Read more
Impact Snapshot
Event Time:
ZGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZGNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZGNX alerts
High impacting Zogenix, Inc. news events
Weekly update
A roundup of the hottest topics